Congratulations to Victor Ambros and Gary Ruvkun, this year’s Nobel Laureates, for their pioneering discovery of microRNAs—tiny but powerful molecules that regulate gene expression and have reshaped our understanding of biology, aging, cancer, and development.
At TAmiRNA, we’ve been deeply inspired by this breakthrough and have dedicated over 10 years to harnessing the potential of microRNAs. We’ve developed cutting-edge diagnostic tools that leverage microRNAs as biomarkers, with our regulatory approved hepatomiR® device leading the way in improving liver cancer patient care across Europe.
Our passion for innovation has resulted in over 100 scientific publications, and we’re proud to contribute to advancing this transformative field.
The Nobel Prize serves as a reminder of the impact that these discoveries can have on medical technologies, and we’re committed to pushing the boundaries further—developing novel diagnostic and therapeutic solutions based on this incredible science. 🔬
Let’s continue to drive innovation in healthcare together!
Reach out to info@tamirna.com to discuss our latest developments and how TAmiRNA’s services fcan assist your business!
